Summary: Pancreatic phospholipase A 2 and non-pancreatic ascitic phospholipases A 2 were studied in sera of healthy individuals and of patients suffering from sepsis or acute pancreatitis. In gel filtration experiments, immunoreactive ascitic phospholipase A 2 , as determined in serum by a time-resolved fluoroimmunoassay, eluted either unassociated with an apparent M r of 10 000 -14 000 or associated with proteins of high molecular mass. Catalytically active ascitic phospholipase A 2 was associated with high molecular weight proteins. In acute pancreatitis the catalytically active and immunoreactive pancreatic phospholipase A 2 eluted mainly as a protein of M r of 14000. The results of the gel filtration experiments indicate that pancreatic phospholipase A 2 is not associated with other proteins in human serum, whereas ascitic phospholipase A 2 is associated with protein(s) of relative high molecular weight, or exists in different polymeric forms. We also purified phospholipase A 2 from sera of healthy individuals by ion exchange chromatography and HPLC. The enzyme was homogenous, displayed an M r of approximately 13 500 as judged by SDS-polyacrylamide gel electrophoresis, and reacted with an antibody raised against ascitic phospholipase A 2 .
Introduction
" . . . , ,. 111 merous cells and tissues including human tonsils, kidHigh concentrations of phospholipase A 2 *) catalytic ney, rheumatoid synovial cells, spleen and lung (8, 9) . activity have been found in sera of patients suffering The cytokines, interleukin-1 and tumour necrosis facfrom a number of common and severe diseases, in-tor, increase the mRNA levels of group II phosphocluding septic shock (1), rheumatoid arthritis (2), lipase A 2 and the secretion of the enzyme (10, 11) . acute pancreatitis (3), peritonitis (4) and multiple in-^ , " , , . " « , /C x c , « i, r A u u The mechanism of the elevation of extracellular group mries (5) . Secretory phospholipases A 2 have been " , , including serum and plasma (14) . The cellular source Phospholipase A 2 , phosphatide 2-acylhydrolase (EC 3.1.1.4) of this enzyme is unknown. An antibody raised earlier against purified human pancreatic phospholipase A 2 (15) does not react with the ascitic phospholipase A 2 (14) .
The purpose of the present work was to study the ascitic and pancreatic-type phospholipases A 2 in normal sera and in sera of patients suffering from acute pancreatitis or sepsis. We found that there are two pools of ascitic phospholipase A 2 in serum: free and protein-associated enzymes. In addition, we report here the isolation of phospholipase A 2 from human serum as a nearly homogeneous protein as judged by SDS-polyacrylamide gel electrophoresis. (17, 18) . The enzyme proteins were measured immunochemically by time-resolved fluoroimmunoassays with antisera raised in rabbits against 1) the phospholipase A 2 purified from the ascitic fluid of patients with ovarian carcinoma and peritoneal carcinosis (ascitic fluid phospholipase A 2 ), and 2) the secretory pancreatic phospholipase A 2 purified from human pancreatic tissue (pancreatic phospholipase A 2 ), as described elsewhere (14, 19 , for ascitic and pancreatic phospholipase A 2 , respectively).
Materials and Methods

Patients
Normal sera were obtained from three healthy laboratory workers. The sepsis sera were from hospitalized patients from the University Hospital of Ulm (Germany). Sera of a patients suffering from acute pancreatitis were from the University Central Hospital of Turku (Finland). Sera were stored at -20°C until used.
Protein determination
Protein was determined according to the method of Lowry et al. (20) .
Statistical analysis
Student's t-test was used for the statistical analysis.
Chromatography
Gel filtration chromatography of serum was performed on a 1.6 χ 40 cm Sephadex G75 (Pharmacia, Uppsala, Sweden) column equilibrated with 20 mmol/1 Tris-HCl (pH 8) buffer containing 0.15 mol/1 NaCl. The column was eluted at a flow rate of 24 ml/h. The volumes of the chromatographed sera were 1-2 ml.
Phospholipase A 2 was purified from serum by ion exchange chromatography on a 1.6 χ 10cm CM-Sepharose CL6B (Pharmacia, Uppsala, Sweden) column equilibrated and washed free of anionic proteins with 2.5 mmol/1 Tris-HCl (pH 7.5) containing 0.15 mol/1 NaCl. The column was eluted stepwise with buffered 0.5 mol/1 and 1.5 mol/1 NaCl.
The phospholipase A 2 -rich pool from ion exchange or gel filtration chromatography was applied to a reverse-phase C8-column (Aquapore Octyl RP 300, 0.46 χ 22 cm, Brownlee Lab., Santa Clara, CA, USA) for HPLC. The column was equilibrated, and after application of the sample, washed free of unbound proteins with 1 ml/1 trifluoroacetic acid. Phospholipase A 2 was eluted by using an acetonitrile gradient (95% acetonitrile/1 ml/1 trifluoroacetic acid from 0 to 15% during 5 minutes and thereafter from 15 to 50% during 90 minutes.
Electrophoresis and immunoblotting SDS-polyacrylamide gel electrophoresis was performed with the PhastSystem of Pharmacia (Uppsala, Sweden) using PhastGel gradient polyacrylamide gels (8 -25%). Protein bands were visualized with Coomassie blue staining. Proteins were transferred to nitrocellulose filters with the PhastSystem semidry immunoblotting device as described by the manufacturer. Nitrocellulose filters were immunostained by using a Vectastain ABC-kit (Vector Laboratories Inc., Burlingame, CA, USA). Phospholipase A 2 purified from normal serum was detected with affinity-purified anti-ascitic phospholipase A 2 antiserum (7 mg/1). The phospholipase A 2 binding component was indentified using rabbit antiserum to human albumin (Dako, Glostrup, Denmark).
Results
Characterization of two phospholipases A 2 in serum in sepsis and acute pancreatitis
In gel filtration chromatography, immunoreactive ascitic phospholipase A 2 eluted in two peaks, one associated with high molecular mass proteins, and the other unassociated with an apparent M r of 10000 -14000 in normal serum and in sera of patients with sepsis and acute pancreatitis. Catalytically active phospholipase A 2 eluted mainly in association with high molecular-weight proteins in normal serum and in serum from a septic patients ( fig. 1 a, b) . In the serum of a patient with acute pancreatitis, the immunoreactivity and catalytic activity of pancreatic phospholipase A 2 eluted mainly as a protein of Μ τ about 14000 ( fig. 1 c) . The catalytic activity and the content of pancreatic and ascitic phospholipase A 2 in the sera used in the gel filtration studies are presented in table 1. Table 2 gives the elution of the catalytic activity and immunoreactivity of pancreatic and ascitic phospholipase A 2 in the sera chromatographed on Sephadex G75.
The concentration of ascitic phospholipase A 2 was within the reference interval in patients suffering from sepsis (p = 0.464) or acute pancreatitis (p = 0.6590) (tab. 3). The concentration of pancreatic phospholipase A 2 was elevated in pancreatitis (p = 0.0022) but not in sepsis (p = 0.1083). The catalytic activity was clearly higher than normal in sepsis and pancreatitis (p = 0.000 and p = 0.002, respectively). 
Macromolecular phospholipase A 2 in serum
The fractions containing phospholipase A 2 associated with high molecular weight proteins after gel filtration chromatography were pooled and applied to a reverse phase column for HPLC. Phospholipase A 2 eluted at approximately 30 per cent of acetonitrile (14) . After chromatography, phospholipase A 2 -active fractions were incubated with NaSCN, and phospholipase A 2 was separated from the main protein peak by Sephadex G75 gel filtration chromatography ( fig. 2) . As a control experiment, phospholipase A 2 -containing fractions obtained from reversed phase chromatography were chromatographed without NaSCN treatment on a Sephadex G75 column. Phospholipase A 2 eluted in the fraction of high molecular weight proteins (data not shown). fig. 2) .
Purification of phospholipase A 2 from normal serum
In ion exchange chromatography of normal serum, immunoreactive ascitic phospholipase A 2 was eluted in two discrete peaks and phospholipase A 2 catalytic activity in one peak by 1.5 mol/1 NaCl (fig. 4) . Only traces of immunoreactive ascitic phospholipase A 2 were eluted by 0.5 mol/1 NaCl. The catalytically active phospholipase A 2 was found to represent only about 5 per cent of the total phospholipase A 2 in serum. The major fraction of phospholipase A 2 immunoreactivity (nearly 95 per cent of the total phospholipase A 2 in serum, fig. 4 ), which was contained in this peak, was further purified by HPLC. From the application of 20 ml of serum (1200 mg of protein) to the ion exchange column, the procedure yielded 0.490 mg of ascitic phospholipase A 2 , devoid of catalytic activity. The apparent M T of the purified serum-phospholipase A 2 was approximately 13 500 in SDS-polyacrylamide gel electrophoresis. The antibody against ascitic phospholipase A 2 recognized the purified phospholipase A 2 in immunoblotting ( fig. 3 ). 
Discussion
Two phospholipases A 2 (ascitic and pancreatic phospholipase A 2 ) were characterized in normal serum and in sera of patients suffering from sepsis or acute pancreatitis. In gel filtration chromatography on Sephadex G75, ascitic phospholipase A 2 eluted with proteins of high (M r 67000) and low (Af r 10000-14000) molecular mass as measured with time resolved fluoroimmunoassay. Pancreatic secretory phospholipase A 2 eluted as a protein of Af r about 14 000. Vadas (1) reported that phospholipase A 2 from plasma in septic shock had an M r of approximately 14000 in gel filtration chromatography on Sephadex G75. In the present study, we purified from normal serum a phospholipase A 2 that reacted with the antibody raised against ascitic fluid phospholipase A 2 but was devoid of catalytic activity. This enzyme protein had an M r of approximately 13 500. However, in our gel filtration experiments, the catalytic activity of phospholipase A 2 eluted mainly in association with high molecular weight protein(s), and only insignificant activity was found in the fractions containing proteins of low molecular mass. The concentration of ascitic phospholipase A 2 in sera of patients suffering from acute pancreatitis were within the reference interval, but extremely high compared with the concentration of pancreatic phospholipase A 2 in the same serum samples. The possibility that the anti-ascitic-phospholipase A 2 antibody recognizes some non-phospholipase A 2 material cannot be excluded unequivocally by the methods used. However, we have excluded cross reactions with human albumin, human IgG, collagen type III and collagen type IV in the immunoassay for ascitic phospholipase A 2 (results not shown).
Cellular calcium-dependent phospholipases A 2 may be classified into at least two groups according to distinct characteristics of their primary structure (6) . In addition to the pancreas, pancreatic-type phospholipase A 2 (group I) is present in cobra venom, spleen and lung (21 -23) . Phospholipases A 2 from platelet (24), spleen (25) , liver (26) and ascitic fluid (27, 28) resemble the phospholipases A 2 found in crotalic snake venoms in their primary structure and are classified in group II. Antibodies against group I phospholipases A 2 do not cross-react with group II phospholipases A 2 (29, 26, 30) . Our results show that human ascitic phospholipase A 2 and pancreatic phospholipase A 2 are immunologically distinct proteins.
The present gel filtration studies indicate that ascitic phospholipase A 2 is partly associated with high molecular weight protein(s) in serum. Incubation of the phospholipase A 2 -containing high molecular weight peak with NaSCN dissociates phospholipase A 2 from other proteins. Characterization of this protein by SDS-PAGE revealed one band of M T approximately 67000. Additionally, the anti-albumin antibody recognized this protein in immunoblotting. It was reported earlier that phospholipase A 2 binds to albumin (31) . Binding to other proteins such as lipoproteins cannot be excluded.
Ascitic phospholipase A 2 may also exist in different polymeric forms in serum (32, 33) . Rat lung contains, in addition to a high molecular weight phospholipase A 2 , two minor fractions with phospholipase A 2 activity: a monomer (M r 12000) and a dimer (M r 25000) (34) . An antiserum raised against Naja naja venom phospholipase A 2 cross-reacted with 30000 and 45 000 proteins from guinea pig alveolar macrophages and rat lymphocytes, and displayed a weak activity toward a M r 14000 protein (35) . Similarly, an antibody against denatured rat platelet phospholipase A 2 detected three protein bands of M r about 14000, 32000 and 44000 in rat platelet lysate (36) . In addition to low molecular mass phospholipases A 2 (37) , enzymes of high molecular mass have been found in monocytic leukaemia cells (38, 39) , rat serum (40), rat renal mesangial cells (41) and rat lung (34) .
The results of the present gel filtration and immunoblotting experiments indicate that the ascitic phospholipase A 2 may either be associated with a protein of higher molecular weight, or exists in different polymeric forms in serum. Polymerization or protein association may change the catalytic properties of the enzyme.
